Dynamic and Isometric Strength Training in Older Adults With Hypertension

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorRaphael Mendes Ritti Dias

About this trial

This feasibility study aims to evaluate the effects of dynamic strength training and isometric strength training on cardiovascular health indicators, mental health, and neuromuscular fitness in older adults with hypertension. Participants will be randomly assigned to one of the two training modalities and will complete supervised exercise sessions throughout the intervention period. The study will provide preliminary evidence regarding the safety, acceptability, and potential impact of each training modality on health outcomes in this population.

Eligibility criteria

Qualifiers

Diagnosis of arterial hypertension and currently taking antihypertensive medication

Age 60 years or older

Resting blood pressure below 160/95 mmHg

No high cardiovascular risk according to the American College of Sports Medicine criteria (for participants with type 2 diabetes, glycemic control with fasting glucose <100 mg/dL and postprandial glucose <140 mg/dL)

Disqualifiers

Presence of acute illnesses, such as influenza, sinusitis, gastroenteritis, urinary tract infection, fever, inflammatory processes, or any clinical condition requiring rest or that may compromise safety during assessments or training.

Decompensated clinical conditions, including: Blood pressure spikes, Chest pain, Uncontrolled arrhythmias, Shortness of breath at rest, Asthma exacerbations, Decompensated diabetes mellitus, characterized by Persistently elevated blood glucose levels (fasting glucose > 180 mg/dL or postprandial glucose > 250 mg/dL)

Irregular use of medication

Any unstable clinical condition or condition that represents additional risk for the practice of physical exercise.

Trial design

Treatments tested in this trial

  • Dynamic Strength Training
  • Isometric Strength Training
  • No supervised intervention Control

Treatment groups

60 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Raphael Mendes Ritti Dias

Lead sponsor

University of Nove de Julho

Sponsor institution